K36 Therapeutics


K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.

Employees

1-10

Links


Org chart

Terrence Connolly
President and Chief Executive Officer
Collapse
Chad Lewis
Executive Director Of Technical Operations
M. Travis Quigley
SVP. Head of Clinical Development

Teams

This company has no teams yet


Offices